Bristol immune drug shows strong effect in melanoma study

Bristol immune drug shows strong effect in melanoma study

By Ben Hirschler MADRID (Reuters) - Bristol-Myers Squibb's immunotherapy drug Opdivo produced markedly improved response rates with fewer toxic side effects compared to chemotherapy in a major melanoma study, underscoring its potential as a new treatment option. The data has been keenly awaited since this is the first presentation of results from a pivotal Phase III clinical trial of a promising new class of drugs designed to help the body's own immune system fight cancer. ...

You are reading an article about Bristol immune drug shows strong effect in melanoma study and you can find this article in url https://we-care-you.blogspot.com/2014/09/bristol-immune-drug-shows-strong-effect_29.html,You can copy paste and use the article Bristol immune drug shows strong effect in melanoma study , may this is very interesting for you and others ,but don't forget to take this link Bristol immune drug shows strong effect in melanoma study for article source, Thanks.